Skip to main content

Table 1 Assessments used in the 2022 ACR/EULAR GCA classification criteria and the modified version in this study

From: Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis

2022 ACR/EULAR GCA classification criteria

Modified ACR/EULAR GCA classification criteria in the present study

Score

Absolute requirement

 Age 50 years at time of diagnosis

Unmodified

Additional clinical criteria

 Morning stiffness in the shoulders/neck

PMR

 + 2

 Sudden visual loss

Sudden visual abnormalities or visual loss

 + 3

 Jaw or tongue claudication

Jaw claudication

 + 2

 New temporal headaches

New headaches not explained by other diseases

 + 2

 Scalp tenderness

Unmodified

 + 2

 Abnormal examination of the temporal artery

Unmodified

 + 2

Laboratory, imaging, and biopsy criteria

 Maximum ESR ≥ 50 mm/hour or maximum CRP ≥ 10 mg/L

Unmodified

 + 3

 Positive temporal artery biopsy or halo sign on temporal artery

Ultrasound

Positive temporal artery biopsy

 + 5

 Bilateral axillary involvement

Unmodified

 + 2

 FDG‐PET activity throughout

Aorta

Wall thickening or aneurysm on CT/CTA or MRI/MRA, and/or PET-CT activity throughout the aorta

 + 2

  1. ACR American College of Rheumatology, CTA computed tomography angiography, FDG fluorodeoxyglucose, JPVAS Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis, MRA magnetic resonance angiography